Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1995 1
1997 1
2005 1
2006 3
2008 1
2009 1
2013 1
2014 2
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
Daudén E, Puig L, Ferrándiz C, Sánchez-Carazo JL, Hernanz-Hermosa JM; Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Daudén E, et al. Among authors: hernanz hermosa jm. J Eur Acad Dermatol Venereol. 2016 Mar;30 Suppl 2:1-18. doi: 10.1111/jdv.13542. J Eur Acad Dermatol Venereol. 2016. PMID: 26812550
Risk factors in pediatric dermatologic surgery.
Alfageme Roldan F, Ciudad Blanco C, Campos Dominguez M, Suárez Fernández R, Hernanz Hermosa JM, Lázaro Ochaita P. Alfageme Roldan F, et al. Among authors: hernanz hermosa jm. Dermatol Online J. 2009 Sep 15;15(9):2. Dermatol Online J. 2009. PMID: 19930989
[Superficial mycoses in immunosuppressed patients].
Hernanz Hermosa JM, Lázaro Ochaita P. Hernanz Hermosa JM, et al. Rev Clin Esp. 1995 Oct;195 Suppl 3:49-55. Rev Clin Esp. 1995. PMID: 9441306 Review. Spanish. No abstract available.
Patient perspectives on the management of atopic dermatitis.
Zuberbier T, Orlow SJ, Paller AS, Taïeb A, Allen R, Hernanz-Hermosa JM, Ocampo-Candiani J, Cox M, Langeraar J, Simon JC. Zuberbier T, et al. Among authors: hernanz hermosa jm. J Allergy Clin Immunol. 2006 Jul;118(1):226-32. doi: 10.1016/j.jaci.2006.02.031. Epub 2006 May 2. J Allergy Clin Immunol. 2006. PMID: 16815160
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT).
Paul C, Puig L, Kragballe K, Luger T, Lambert J, Chimenti S, Girolomoni G, Nicolas JF, Rizova E, Lavie F, Mistry S, Bergmans P, Barker J, Reich K; TRANSIT Investigators. Paul C, et al. Br J Dermatol. 2014 Feb;170(2):425-34. doi: 10.1111/bjd.12646. Br J Dermatol. 2014. PMID: 24116959 Free article. Clinical Trial.
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis.
Reich K, Puig L, Paul C, Kragballe K, Luger T, Lambert J, Chimenti S, Girolomoni G, Nicolas JF, Rizova E, Brunori M, Mistry S, Bergmans P, Barker J; TRANSIT Investigators. Reich K, et al. Br J Dermatol. 2014 Feb;170(2):435-44. doi: 10.1111/bjd.12643. Br J Dermatol. 2014. PMID: 24116868 Clinical Trial.
13 results